2006Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhiRequires access

Experimental research on effect of insulin-like growth factor on placentas of intrauterine growth retardation rats

Shuqin Li

Open publisher page 0 citations

Abstract

[Objective] This study aimed to explore the effect and its mechanism of L-arginine on IUGR rats by the alterations of insulin-like growth factor-Ⅰ(IGF-Ⅰ), insulin-like growth factor-Ⅱ(IGF-Ⅱ) and insulin-like growth factor binding protein 3 in the placentas of IUGR rats after different doses of L-arginine were administered. [Methods] After establishment of IUGR model by passive smoking, thirty-six rats were divided into four groups: Control, Model, Low dose (100 mg/kg L-arginine) and High dose (200 mg/kg L-arginine) (n=9 each). The levels of IGF-Ⅰ, IGF-Ⅱ and IGFBP-3 in placentas were measured by enzyme-linked immunoadsordent assay (ELISA). [Results] The average placental weight of L-arginine treated groups were increased significantly compared with Model group (P 0.01). The placental levels of IGF-Ⅰand IGF-Ⅱin L-arginine treated groups were increased significantly than those of Model group (P 0.01). The placental levels of IGFBP-3 in L-arginine treated groups were decreased significantly than those of Model group (P 0.01). [Conclusions] L-arginine can increase the levels of IGF-Ⅰand IGF-Ⅱ, decrease the levels of IGFBP-3 in placentas of IUGR rat, and improve the development of fetal rats.

About this research paper

What this paper is about

[Objective] This study aimed to explore the effect and its mechanism of L-arginine on IUGR rats by the alterations of insulin-like growth factor-Ⅰ(IGF-Ⅰ), insulin-like growth factor-Ⅱ(IGF-Ⅱ) and insulin-like growth factor binding protein 3 in the placentas of IUGR rats after different doses of L-arginine were administered. [Methods] After establishment of IUGR model by passive smoking, thirty-six rats were divided into four groups: Control, Model, Low dose (100 mg/kg L-arginine) and High dose (200 mg/kg L-arginine) (n=9 each). The levels of IGF-Ⅰ, IGF-Ⅱ and IGFBP-3 in placentas were measured by enzyme-linked immunoadsordent assay (ELISA). [Results] The average placental weight of L-arginine treated groups were increased significantly compared with Model group (P 0.01). The placental levels of IGF-Ⅰand IGF-Ⅱin L-arginine treated groups were increased significantly than those of Model group (P 0.01). The placental levels of IGFBP-3 in L-arginine treated groups were decreased significantly than those of Model group (P 0.01). [Conclusions] L-arginine can increase the levels of IGF-Ⅰand IGF-Ⅱ, decrease the levels of IGFBP-3 in placentas of IUGR rat, and improve the development of fetal rats.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] This study aimed to explore the effect and its mechanism of L-arginine on IUGR rats by the alterations of insulin-like growth factor-Ⅰ(IGF-Ⅰ), insulin-like growth factor-Ⅱ(IGF-Ⅱ) and insulin-like growth factor binding protein 3 in the placentas of IUGR rats after different doses of L-arginine were administered. [Methods] After establishment of IUGR model by passive smoking, thirty-six rats were divided into four groups: Control, Model, Low dose (100 mg/kg L-arginine) and High dose (200 mg/kg L-arginine) (n=9 each). The levels of IGF-Ⅰ, IGF-Ⅱ and IGFBP-3 in placentas were measured by enzyme-linked immunoadsordent assay (ELISA). [Results] The average placental weight of L-arginine treated groups were increased significantly compared with Model group (P 0.01). The placental levels of IGF-Ⅰand IGF-Ⅱin L-arginine treated groups were increased significantly than those of Model group (P 0.01). The placental levels of IGFBP-3 in L-arginine treated groups were decreased significantly than those of Model group (P 0.01). [Conclusions] L-arginine can increase the levels of IGF-Ⅰand IGF-Ⅱ, decrease the levels of IGFBP-3 in placentas of IUGR rat, and improve the development of fetal rats.

Key concepts: Arginine, Endocrinology, Internal medicine, Insulin-like growth factor, Growth factor, Insulin, Medicine, Placenta

Related papers

Back to paper searchBrowse research topicsOriginal source
Experimental research on effect of insulin-like growth factor on placentas of intrauterine growth retardation rats — Research Paper | ScholarLens